We thus aimed to investigate the potential synergistic effect of VPA and ETO on inhibiting melanoma and to examine whether the sequential order of VPA and ETO could be a key factor in exerting the synergistic anticancer effect. The gene discussed is RUNX1T1; the disease is melanoma.